Cargando…

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology

The Organisation of European Cancer Institutes OECI working group on Health Economics and Cost Benefit in Oncology suggests four actions that are needed to improve alignment and integration between clinicians, researchers, and Health Technology Assessment (HTA) experts and agencies: 1) HTA expertise...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Harten, WH, Retèl, VP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2016
Materias:	Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130332/ https://www.ncbi.nlm.nih.gov/pubmed/27994642 http://dx.doi.org/10.3332/ecancer.2016.686

Ejemplares similares

Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation
por: van Harten, WH, et al.
Publicado: (2016)

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology
por: Joosten, S.E.P., et al.
Publicado: (2016)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

Economic Implications of Potential Changes to Regulatory and Reimbursement Policies for Medical Devices
por: Reed, Shelby D., et al.
Publicado: (2007)

Excellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies
por: Rajan, A., et al.
Publicado: (2015)

Family medicine and physician reimbursement: a US perspective and the RCGP International and Overseas Network
por: Uko, Ayotunde Monica
Publicado: (2018)

Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis
por: Stoker, Lennart Jan, et al.
Publicado: (2019)

Emergency Physician Reimbursement: Getting Shortchanged or Shrewdly Negotiating?
por: Venkatesh, Arjun K., et al.
Publicado: (2020)

Innovative digital technologies for quality assurance of diagnosis of human African trypanosomiasis
por: Hasker, Epco, et al.
Publicado: (2018)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis
por: Yi, Hongbin, et al.
Publicado: (2023)

The Role of Funding and Policies on Innovation in Cancer Drug Development
por: Kanavos, P, et al.
Publicado: (2010)

Staff perceptions of change resulting from participation in a European cancer accreditation programme: a snapshot from eight cancer centres
por: Rajan, Abinaya, et al.
Publicado: (2015)

Precision oncology in Latin America: current situation, challenges and perspectives
por: Calderón-Aparicio, Ali, et al.
Publicado: (2019)

International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
por: de Campos Vieira Abib, Simone, et al.
Publicado: (2022)

Expertise and Technology
por: Hoc, Jean-Michel
Publicado: (2013)

Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study
por: Hsu, Jason C, et al.
Publicado: (2019)

Affordable Health Insurance Options for Small Business and Low-Wage Workers Remains Elusive: Experience With New Health Reimbursement Arrangements in New Jersey
por: Cantor, Joel C., et al.
Publicado: (2023)

Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis
por: Hallinan, Christine Mary, et al.
Publicado: (2021)

PACE Continuous Innovation Indicators—a novel tool to measure progress in cancer treatments
por: Paddock, Silvia, et al.
Publicado: (2015)

Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening
por: Dondorp, Wybo, et al.
Publicado: (2015)

Responsible implementation of expanded carrier screening
por: Henneman, Lidewij, et al.
Publicado: (2016)

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2020)

Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic
por: VanderWerf, Mark, et al.
Publicado: (2022)

The Physical Therapy Compact: From Development to Implementation
por: ADRIAN, LESLIE
Publicado: (2017)

The NICE Evidence Standards Framework for digital health and care technologies – Developing and maintaining an innovative evidence framework with global impact
por: Unsworth, Harriet, et al.
Publicado: (2021)

Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)

Implementing learning health systems in the UK NHS: Policy actions to improve collaboration and transparency and support innovation and better use of analytics
por: Scobie, Sarah, et al.
Publicado: (2019)

Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
por: Lennan, E, et al.
Publicado: (2012)

Adequate reimbursement is crucial to support cost-effective rapid on-site cytopathology evaluations
por: Al-Abbadi, Mousa A., et al.
Publicado: (2010)

Implementation process and challenges for the community-based integrated care system in Japan
por: Tsutsui, Takako
Publicado: (2014)

Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study
por: Mpofu, Philani, et al.
Publicado: (2023)

The Development of Statewide Policies and Procedures to Implement Telehealth for Part C Service Delivery
por: COLE, BETH, et al.
Publicado: (2016)

Palliative oncology and palliative care
por: Strang, Peter
Publicado: (2022)

CERN: a model for international cooperation in science
por: Rubbia, Carlo
Publicado: (1987)

Editorial: Neural implementation of expertise
por: Bilalić, Merim, et al.
Publicado: (2015)

Trends in Reimbursement for Index Surgical Oncology Procedures in Contemporary Practice: Declining Reimbursement for Surgical Oncology Procedures—How Low Do We Go?
por: Hydrick, Thomas C., et al.
Publicado: (2022)

Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals
por: Carlson, Josh, et al.
Publicado: (2009)

Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations
por: Binder, Louise, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40s1qg9te4t0rs4qo822no7ne9